Human SA gene polymorphisms are associated with non-high-density lipoprotein cholesterol in postmenopausal women: A pilot study

Maturitas

Volumn 62, Issue 1, 2009, Pages 66-71

  Lin, Ming Wei ^a,b   Hwu, Chii Min ^a,b   Liou, Teh Ling ^b   Hsiao, Li Chuan ^b   Ho, Low Tone ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Human SA gene; Insulin resistance; Menopause; Non HDL C

Indexed keywords

LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DNA POLYMORPHISM; DYSLIPIDEMIA; EXON; FEMALE; GENE; GENOTYPE; HAPLOTYPE; HOMOZYGOSITY; HUMAN; HUMAN SA GENE; INSULIN RESISTANCE; INTRON; MAJOR CLINICAL STUDY; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PHENOTYPE; POSTMENOPAUSE; PROMOTER REGION;

AGED; CHINA; CHOLESTEROL; COENZYME A LIGASES; CROSS-SECTIONAL STUDIES; EXONS; FEMALE; HUMANS; HYPERLIPIDEMIAS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PROMOTER REGIONS, GENETIC;

EID: 58849088820     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2008.11.002     Document Type: Article

References (34)

1. Mosca L., Manson J.E., Sutherland S.E., Langer R.D., Manolio T., and Barrett-Connor E. Cardiovascular disease in women. A statement for healthcare profesionals from the American Heart Association. Circulation 96 (1997) 2468-2482
2. Lerner D.J., and Kannel W.B. Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population. Am Heart J 111 (1986) 383-390
3. Carr M.C. The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab 88 (2003) 2404-2411
4. Bittner V. Lipoprotein abnormalites related to women's health. Am J Cardiol 90 suppl (2002) 77i-84i
5. Schaefer E.J., Lamon-Fava S., Cohn S.D., et al. Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study. J Lipid Res 35 (1994) 779-792
6. Shai I., Rimm E.B., Hankinson S.E., et al. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women. Potential implications for clinical guidelines. Circulation 110 (2004) 2824-2830
7. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaulation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
8. van Beresteijn E.C.H., Korevaar J.C., Huijbregts P.C.W., Schouten E.G., Burema J., and Kok F.J. Perimenopausal increase in serum cholesterol: a 10-year longitudinal study. Am J Epidemiol 137 (1993) 383-392
9. Hak A.E., Witteman J.C.M., Hugens W., et al. The increase in cholesterol with menopause is associated with the apolipoprotein E genotype. A population-based longitudinal study. Atherosclerosis 175 (2004) 169-176
10. Demissie S., Cupples L.A., Shearman A.M., et al. Estrogen receptor-α variants are associated with lipoprotein size distribution and particle levels in women: the Framingham Heart Study. Atherosclerosis 185 (2006) 210-218
11. Chamberlain A.M., Folsom A.R., Schreiner P.J., Boerwinkle E., and Ballantyne C.M. Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: the atherosclerosis risk in comunities (ARIC) Study. Atherosclerosis 200 (2008) 322-328
12. Tayler K.D., Norris J.M., and Rotter J.I. Genome-wide association. Which do you want first: the good news, the bad news, or the good news?. Diabetes 56 (2007) 2844-2848
13. Iwai N., and Inagami T. Isolation of preferentially expressed genes in the kidneys of hypertensive rats. Hypertension 17 (1991) 161-169
14. Samani N.J., Whitmore S.A., Kaiser M.A., et al. Chromosomal assignment of the human SA gene to 16p13.11 and demonstration of its expression in the kidney. Biochem Biophy Res Commun 199 (1994) 862-868
15. Iwai N., Katsuya T., Mannami T., et al. Association betwen SAH, an acyl-CoA synthetase gene, and hypertriglyceridemia, obesity, and hypertension. Circulation 105 (2002) 41-47
16. Bach A.C., Ingenbleek Y., and Frey A. The usefulness of dietary medium-chain triglycerides in body weight control: fact or fancy?. J Lipid Res 37 (1996) 708-726
17. 14) fatty acids studied in isolated liver cells. Biochim Biophys Acta 1004 (1989) 187-195
18. Black P.N., Færgeman N.J., and Dirusso C.C. Long-chain acyl-CoA-dependent regulation of gene expression in bacteria, yeast and mammals. J Nutr 130 (2000) 305S-309S
19. Coleman R.A., Lewin T.M., Van Horn C.G., and Gonzalez-Baró M.R. Do long-chain acyl-CoA synthetases regulate fatty acid entry into synthetic versus degradative pathways?. J Nutr 132 (2002) 2123-2126
20. Mudd J.O., Borlaug B.A., Johnston P.V., et al. Beyond low-density lipoprotein cholesterol. Defining the role of low-density lipoprotein heterogeneity in coronary artery disease. J Am Coll Cardiol 50 (2007) 1735-1741
21. Hwu C.M., Fuh J.L., Hsiao C.F., et al. Waist circumference predicts metabolic cardiovascular risk in postmenopausal Chinese women. Menopause 10 (2003) 73-80
22. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
23. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
24. 0,120): comparison with other measures. Diabetes Res Clin Pract 47 (2000) 177-184
25. Zhao J.H., Lissarrague S., Esioux L., and Sham P.C. Genecounting: haplotype analysis with missing genotypes. Bioinformatics 18 (2002) 1694-1695
26. Fujino T., Take Y.A., Sone H., et al. Molecular identification and characterization of two medium-chain acyl-CoA synthetases, MACS1 and the Sa gene product. J Biol Chem 276 (2001) 35961-35966
27. Lewis G.F., and Steiner G. Acute effects of insulin in the control of VLDL production in humans. Diabetes Care 19 (1996) 390-392
28. Krauss R.M. Lipids and lipoproteins in patients with type 2 diabetes. Diabetes Care 27 (2004) 1496-1504
29. Haketa A., Soma M., Nakayama T., et al. Two medium-chain acyl-coenzyme A synthetase genes, SAH and MACS1, are associated with plasma high-density lipoprotein cholesterol levels, but they are not associated with essential hypertension. J Hypertens 22 (2004) 1903-1907
30. Nabika T., Bonnardeaux A., James M., et al. Evaluation of the SA locus in human hypertension. Hypertenion 25 (1995) 6-13
31. Benjafield A.V., Iwai N., Ishikawa K., Wang W.Y.S., and Morris B.J. Overweight, but not hypertension, is associated with SAH polymorphisms in Caucasians with essential hypertension. Hypertens Res 26 (2003) 591-595
32. Tikhonoff V., Staessen J.A., Kuznetsova T., et al. SAH gene variants revisited in the European project on genes in hypertension. J Hypertens 26 (2008) 244-250
33. Telgmann R., Brand E., Nicaud V., et al. SAH gene variants are associated with obesity-related hypertension in Caucasians: the PEGASE study. J Hypertens 25 (2007) 557-564
34. Iwai N., Mannami T., Tomoike H., Ono K., and Iwanaga Y. An acyl-CoA synthetase gene family in chromosome 16p12 may contribute to multiple risk factors. Hypertension 41 (2003) 1041-1046